Lucienne Costa-Frossard

11PUBLICATIONS
82CO-AUTHORS
Neurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyMedical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 12, 2026
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.

|Mar 28, 2026
Health-Related Quality of Life in Radiologically Isolated Syndrome Resembles Relapsing-Remitting Multiple Sclerosis.

Julián Benito-León, María Díez-Cirarda, Mariano Ruiz-Ortiz

|Jul 29, 2025
Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis.

Enric Monreal, José Ignacio Fernández-Velasco, Susana Sainz de la Maza

|Dec 17, 2024
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients.

Raquel Sainz-Amo, Alexander Rodero-Romero, Enric Monreal

|Sep 28, 2024
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis.

María Inmaculada Domínguez-Mozo, Ignacio Casanova, Enric Monreal

Pageof 2

Frequent Collaborators

6 joint publications

Luisa María Villar

5 joint publications

Susana Sainz-de-la-Maza

4 joint publications

José Meca-Lallana

4 joint publications

Jaime Masjuan